Evidence map›Paper›PMID 29069760›Full record

ArticleOncotarget2017

Up-regulation of CIT promotes the growth of colon cancer cells.

Zehua Wu, Xiangying Zhu, Wendi Xu, Yu Zhang, Lin Chen, Fabo Qiu, Binyuan Zhang, Liqun Wu, Zhihai Peng, Huamei Tang

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Zehua Wu *Department of Hepatobiliary Surgery, The Affiliated Hospital of Qingdao University, Qingdao 266003, People's Republic of China.
Xiangying Zhu *Department of General Surgery, Shanghai Jiaotong University Affiliated First People's Hospital, Shanghai 200080, People's Republic of China.
Wendi XuDepartment of Continuing Medical Education, The Affiliated Hospital of Qingdao University, Qingdao 266003, People's Republic of China.
Yu ZhangDepartment of Pathology, Shanghai Jiaotong University Affiliated First People's Hospital, Shanghai 200080, People's Republic of China.
Lin ChenR & D Department, Shanghai GeneChem Limited Company, Shanghai 201203, People's Republic of China.
Fabo QiuDepartment of Hepatobiliary Surgery, The Affiliated Hospital of Qingdao University, Qingdao 266003, People's Republic of China.
Binyuan ZhangDepartment of Hepatobiliary Surgery, The Affiliated Hospital of Qingdao University, Qingdao 266003, People's Republic of China.
Liqun WuDepartment of Hepatobiliary Surgery, The Affiliated Hospital of Qingdao University, Qingdao 266003, People's Republic of China.
Zhihai PengDepartment of General Surgery, Shanghai Jiaotong University Affiliated First People's Hospital, Shanghai 200080, People's Republic of China.
Huamei TangDepartment of Pathology, Shanghai Jiaotong University Affiliated First People's Hospital, Shanghai 200080, People's Republic of China.
Affiliated Hospital of Qingdao University · CNShanghai First People's Hospital · CNQingdao University · CNShanghai Genon Biological Products (China) · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colon cancer is one of the major causes of cancer mortality worldwide. However, the underlying mechanism and therapeutic targets of colon cancer have not yet been fully elucidated. In the present study, we demonstrate that citron rho-interacting, serine/threonine kinase 21 (CIT) promotes the growth of human colon cancer cells. CIT is overexpressed in human colon cancer tissues and cell lines. High expression of CIT predicts poor survival for patients with colon cancer. In colon cancer cells, CIT knockdown represses cellular proliferation and colony formation. Our

Indexed as

apoptosiscell growthCITcolon cancerp53

Identifiers

PMID29069760
PMCPMC5641103
OpenAlexW2725297161

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.